QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, January 4, 2006, 26(1):193-202; doi:10.1523/JNEUROSCI.2244-05.2006

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (31) Citing Articles via Google Scholar Google Scholar Articles by Lu, J. Articles by Saper, C. B. Search for Related Content PubMed PubMed Citation Articles by Lu, J. Articles by Saper, C. B.

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Identification of Wake-Active Dopaminergic Neurons in the Ventral Periaqueductal Gray Matter

Jun Lu,¹ Thomas C. Jhou,² and Clifford B. Saper^1,2

¹Department of Neurology and ²Program in Neuroscience, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215

Recent evidence suggests that dopamine plays an important role in arousal, but the location of the dopaminergic neurons that may regulate arousal remains unclear. It is sometimes assumed that the dopaminergic neurons in the ventral tegmental area that project to the prefrontal cortex and striatum may regulate the state of arousal; however, the firing of these dopaminergic neurons does not correlate with overall levels of behavioral wakefulness. We identified wake-active dopaminergic neurons by combining immunohistochemical staining for Fos and tyrosine hydroxylase (TH) in awake and sleeping rats. Approximately 50% of the TH-immunoreactive (TH-ir) cells in the ventral periaqueductal gray matter (vPAG) expressed Fos protein during natural wakefulness or wakefulness induced by environmental stimulation, but none expressed Fos during sleep. Fos immunoreactivity was not seen in the substantia nigra TH-immunoreactive cells in either condition. Injections of 6-hydroxydopamine into the vPAG, which killed 55–65% of wake-active TH-ir cells but did not injure nearby serotoninergic cells, increased total daily sleep by 20%. By combining retrograde and anterograde tracing, we showed that these wake-active dopaminergic cells have extensive reciprocal connections with the sleep–wake regulatory system. The vPAG dopaminergic cells may provide the long-sought ascending dopaminergic waking influence. In addition, their close relationship with the dorsal raphe nucleus will require reassessment of previous studies of the role of the dorsal raphe nucleus in sleep, because many of those experiments may have been confounded by the then-unrecognized presence of intermingled wake-active dopaminergic neurons.

Key words: dorsal raphe nucleus; dopamine; arousal; psychostimulants; neurotoxin lesions; neuronal tracing

---

Received June 2, 2005; revised October 30, 2005; accepted November 6, 2005.

This article has been cited by other articles:

				E. E. Benarroch, A. M. Schmeichel, B. N. Dugger, P. Sandroni, J. E. Parisi, and P. A. Low Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia Neurology, July 14, 2009; 73(2): 106 - 112. [Abstract] [Full Text] [PDF]

				C. W. Olanow, M. B. Stern, and K. Sethi The scientific and clinical basis for the treatment of Parkinson disease (2009) Neurology, May 26, 2009; 72(21_Supplement_4): S1 - S136. [Abstract] [Full Text] [PDF]

				N. D. Volkow, G.-J. Wang, F. Telang, J. S. Fowler, J. Logan, C. Wong, J. Ma, K. Pradhan, D. Tomasi, P. K. Thanos, et al. Sleep Deprivation Decreases Binding of [11C]Raclopride to Dopamine D2/D3 Receptors in the Human Brain J. Neurosci., August 20, 2008; 28(34): 8454 - 8461. [Abstract] [Full Text] [PDF]

				C. Burgess, D. Lai, J. Siegel, and J. Peever An Endogenous Glutamatergic Drive onto Somatic Motoneurons Contributes to the Stereotypical Pattern of Muscle Tone across the Sleep-Wake Cycle J. Neurosci., April 30, 2008; 28(18): 4649 - 4660. [Abstract] [Full Text] [PDF]

				C. Blanco-Centurion, D. Gerashchenko, and P. J. Shiromani Effects of Saporin-Induced Lesions of Three Arousal Populations on Daily Levels of Sleep and Wake J. Neurosci., December 19, 2007; 27(51): 14041 - 14048. [Abstract] [Full Text] [PDF]

				A. Y. Deutch and M. Bubser The Orexins/Hypocretins and Schizophrenia Schizophr Bull, November 1, 2007; 33(6): 1277 - 1283. [Abstract] [Full Text] [PDF]

				Y. Zhu, P. Fenik, G. Zhan, E. Mazza, M. Kelz, G. Aston-Jones, and S. C. Veasey Selective Loss of Catecholaminergic Wake Active Neurons in a Murine Sleep Apnea Model J. Neurosci., September 12, 2007; 27(37): 10060 - 10071. [Abstract] [Full Text] [PDF]

				I. Gvilia, F. Xu, D. McGinty, and R. Szymusiak Homeostatic Regulation of Sleep: A Role for Preoptic Area Neurons J. Neurosci., September 13, 2006; 26(37): 9426 - 9433. [Abstract] [Full Text] [PDF]

				M. D. Gjerstad, G. Alves, T. Wentzel-Larsen, D. Aarsland, and J. P. Larsen Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology, September 12, 2006; 67(5): 853 - 858. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help